Table 1.
Different treatment groups in mice.
| Group | Treatment | Duration |
|---|---|---|
| NT | Sterile water (gavage) | Days 1–7 |
| MC | sterile water (gavage) | Days 1–7 |
| 50 μl 0.2 mg/ml LPS (inject) | Day 7 | |
| DEX | 5 mg/kg/d dexamethasone (gavage) | Days 1–7 |
| 50 μl 0.2 mg/ml LPS (inject) | Day 7 | |
| ATF-L | 100 mg/kg/d ATF (gavage) | Days 1–7 |
| 50 μl 0.2 mg/ml LPS (inject) | Day 7 | |
| ATF-M | 200 mg/kg/d ATF (gavage) | Days 1–7 |
| 50 μl 0.2 mg/ml LPS (inject) | Day 7 | |
| ATF-H | 1,000 mg/kg/d ATF (gavage) | Days 1–7 |
| 50 μl 0.2 mg/ml LPS (inject) | Day 7 |
NT: No treatment model group; MC: LPS treatment model group; DEX: Dexamethasone (5 mg/kg) treatment group; ATF-L: ATF 100 mg/kg, ATF-M: ATF 500 mg/kg, ATF-H: ATF 1000 mg/kg.